RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -48.22 Million USD | 50.88% |
| 2021 | -70.34 Million USD | -80.72% |
| 2020 | -69.67 Million USD | -166.88% |
| 2019 | -222.79 Million USD | -30.17% |
| 2018 | -16.27 Million USD | 29.56% |
| 2017 | -10.14 Million USD | 173.69% |
| 2016 | -8.29 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -4.76 Million USD | 35.61% |
| 2023 Q2 | -7.65 Million USD | -60.74% |
| 2022 Q4 | -7.39 Million USD | 46.5% |
| 2022 Q2 | -15.03 Million USD | -183.27% |
| 2022 FY | - USD | 50.88% |
| 2022 Q1 | -5.3 Million USD | 78.21% |
| 2022 Q3 | -13.82 Million USD | 8.02% |
| 2021 Q3 | -17.67 Million USD | 0.0% |
| 2021 FY | - USD | -80.72% |
| 2021 Q4 | -24.35 Million USD | -37.76% |
| 2020 FY | - USD | -166.88% |
| 2019 FY | - USD | -30.17% |
| 2018 FY | - USD | 29.56% |
| 2017 FY | - USD | 173.69% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 32.109% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -713.421% |
| SQZ Biotechnologies Company | -64.14 Million USD | 24.811% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -177.645% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 151.285% |
| Mesoblast Limited | -62.38 Million USD | 22.7% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -3039.678% |
| Genus plc | 73.7 Million USD | 165.437% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -629.439% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -1259.657% |
| Marizyme, Inc. | -34.28 Million USD | -40.679% |
| ContraFect Corporation | -64.99 Million USD | 25.803% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -449.783% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -965.509% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -3340.343% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -1723.708% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -1975.333% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -9209.405% |
| Accustem Sciences Inc. | -3.74 Million USD | -1187.283% |
| EV Biologics, Inc. | -1.26 Million USD | -3705.997% |
| Q BioMed Inc. | -617.62 Thousand USD | -7708.422% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 1450.14% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -7525.955% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -2011.063% |
| Biomind Labs Inc. | -1.03 Million USD | -4561.645% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 588.276% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -573.442% |
| Skye Bioscience, Inc. | -13.54 Million USD | -255.983% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -3142.343% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -192808.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -1141.582% |
| IMV Inc. | -35.52 Million USD | -35.761% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -203.893% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -1827.567% |
| GB Sciences, Inc. | -1.41 Million USD | -3296.543% |
| Alpha Cognition Inc. | -9.7 Million USD | -396.899% |
| HST Global, Inc. | -5303.00 USD | -909328.625% |
| CSL Limited | 4.78 Billion USD | 101.007% |
| Halberd Corporation | -74.27 Thousand USD | -64826.83% |
| Enzolytics Inc. | -2.12 Million USD | -2172.683% |
| Resverlogix Corp. | -11.74 Million USD | -310.722% |
| Affymax, Inc. | -14.29 Million USD | -237.37% |
| SYBLEU INC | -141.57 Thousand USD | -33965.593% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -1474.494% |
| argenx SE | -216.02 Million USD | 77.675% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 12.852% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 4062.777% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -3117.48% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 12830.042% |
| AVAX Technologies, Inc. | -6.11 Million USD | -688.971% |
| Zenith Capital Corp. | -8.6 Million USD | -460.388% |
| Genscript Biotech Corporation | -248.71 Million USD | 80.61% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -276732.558% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -1871.296% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -27297.912% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -21.672% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -1567.412% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -4509.237% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 717336.764% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -2655.83% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -2410.632% |
| BioStem Technologies, Inc. | -7.55 Million USD | -538.46% |
| ONE Bio Corp. | 13.61 Million USD | 454.271% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -26531.803% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -2244.531% |
| Agentix Corp. | -1.37 Million USD | -3415.713% |
| LadRx Corporation | 412.28 Thousand USD | 11797.548% |
| Cell Source, Inc. | -4.27 Million USD | -1028.77% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -13032.964% |
| Regen BioPharma, Inc. | 1.46 Million USD | 3389.799% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -5047.239% |
| NovAccess Global Inc. | -1.03 Million USD | -4560.528% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 644.704% |
| Itoco Inc. | -1.86 Million USD | -2480.371% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -12604.02% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -4221.416% |
| Kadimastem Ltd | -2.62 Million USD | -1737.652% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -20066.005% |
| CytoDyn Inc. | -18.02 Million USD | -167.497% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -60924.434% |
| Mobile Lads Corp. | -2.24 Million USD | -2051.878% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -394265.852% |
| Qrons Inc. | -40.08 Thousand USD | -120223.844% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -9829.83% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 9243.721% |
| Rebus Holdings, Inc. | -951 Thousand USD | -4971.188% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -4441.106% |
| International Stem Cell Corporation | 202 Thousand USD | 23974.752% |
| Bioxytran, Inc. | -3.82 Million USD | -1162.438% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -91516.641% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -1858.909% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -34.453% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -107071.111% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -1661.395% |
| Neutra Corp. | -181.24 Thousand USD | -26508.44% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -139.233% |
| PureTech Health plc | -11.62 Million USD | -314.785% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -139.249% |
| IXICO plc | -707 Thousand USD | -6721.358% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -527.547% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 0.246% |
| CSL Limited | 4.73 Billion USD | 101.019% |
| Cellectis S.A. | -92.63 Million USD | 47.939% |